| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $92M | $92M | $100M | 0.5% | -7.4% |
| Op. Income | $25M | $24M | $35M | 6.7% | -28.6% |
| Gross Margin | 80.1% | 52.5% | 79.9% | 27.6pp | 0.1pp |
| Net Margin | 34.5% | 28.4% | 19.7% | 6.2pp | 14.9pp |
| EPS (Diluted) | $2.27 | $1.86 | $1.40 | 22.4% | 62.8% |
| Free Cash Flow | $0 | $0 | $0 | — | — |
| Item | Amount |
|---|---|
| REVENUE | $92M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $74M |
| R&D Expenses | $0 |
| Selling & Marketing | $10M |
| General & Administrative | $39M |
| SG&A Expenses | $49M |
| Other Expenses | $102.4K |
| Operating Expenses | $49M |
| Cost & Expenses | $67M |
| OPERATING INCOME | $25M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | $17M |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $32M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $32M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $32M |
| D&A | $0 |
| EBIT | $25M |
| EBITDA | $25M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $92M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $74M |
| R&D Expenses | $0 |
| Selling & Marketing | $10M |
| General & Administrative | $39M |
| SG&A Expenses | $49M |
| Other Expenses | $102.4K |
| Operating Expenses | $49M |
| Cost & Expenses | $67M |
| OPERATING INCOME | $25M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | $17M |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $32M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $32M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $32M |
| D&A | $0 |
| EBIT | $25M |
| EBITDA | $25M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $32M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$34M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $561M |
| Short-Term Investments | $169M |
| Net Receivables | $153M |
| Inventory | $0 |
| Other Current Assets | $49M |
| TOTAL CURRENT ASSETS | $932M |
| PP&E (Net) | $362M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $330M |
| Tax Assets | $46M |
| Other Non-Current Assets | $18M |
| TOTAL NON-CURRENT ASSETS | $755M |
| TOTAL ASSETS | $1.7B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $11M |
| Other Current Liabilities | $117M |
| TOTAL CURRENT LIABILITIES | $195M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $35M |
| Other Non-Current Liabilities | $1M |
| TOTAL NON-CURRENT LIABILITIES | $45M |
| TOTAL LIABILITIES | $241M |
| Common Stock | $1.4B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.4B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.4B |
| TOTAL LIABILITIES & EQUITY | $1.7B |
| Total Debt | $9M |
| Net Debt | -$552M |
